Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase NA 3Phase EARLY_PHASE1 3Phase 3 3Phase 1 3Phase 4 2Phase 1/2 2

Status

Completed 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Long Qt Syndrome 3 1Intestinal Neoplasms 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Completed × Simvastatin × Clear all
NCT01099085 2017-02-17

Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients

Samsung Medical Center

Phase 3 Completed
207 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT00994903 2013-12-02

StatCol

University of Auckland, New Zealand

Phase 3 Completed
132 enrolled

Intestinal Neoplasms

NCT00575601 2009-07-02

Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients

Tehran University of Medical Sciences

Phase 3 Completed
120 enrolled

Long Qt Syndrome 3, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡